Clinical Trial Update: Efficacy and Safety Study of Neoadjuvant Chemotherapy for Local Advanced Triple Negative Breast Cancer Patients

View source ↗

Summary

This clinical trial update discusses the efficacy and safety of neoadjuvant chemotherapy in locally advanced triple-negative breast cancer. The sponsor is Fudan…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Triple-negative Breast Cancer

Snippet

Sponsor: Fudan University | Conditions: Triple Negative Local Advanced Breast Cancer | Status: AVAILABLE